Maarten Egeler
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation 11
- Neurology top 5%
- Neuroblastoma Research and Treatments 3
- Transplantation top 10%
- Renal Transplantation Outcomes and Treatments 3
-
- CAR-T cell therapy research 3
-
- Histiocytic Disorders and Treatments 5
-
- Acute Lymphoblastic Leukemia research 5
-
- Childhood Cancer Survivors' Quality of Life 3
-
- Transplantation: Methods and Outcomes 3
- Co-authors
- Huib N. CaronRosalyn SlaterP.A. VoûteJos P.M. BökkerinkJan de KrakerPeter van SluisA. WesterveldRogier Versteeg
- Cited by
- HematologyNeurologyTransplantation
- Journals
- Bone Marrow Transplantation (5 papers)Blood (4 papers)Biology of Blood and Marrow Transplantation (3 papers)
- Partner nations
- NetherlandsCanadaUnited States
In The Last Decade
Maarten Egeler
28 papers receiving 755 citations
Peers
Comparison fields: 5 of 54
- Hematology 258
- Neurology 291
- Transplantation 30
- Cancer Research 111
- Oncology 145
Countries citing papers authored by Maarten Egeler
This map shows the geographic impact of Maarten Egeler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maarten Egeler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maarten Egeler more than expected).
Fields of papers citing papers by Maarten Egeler
This network shows the impact of papers produced by Maarten Egeler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maarten Egeler. The network helps show where Maarten Egeler may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Maarten Egeler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2015 | 5 | |
| 4 | 2014 | 9 | |
| 5 | 2013 | 6 | |
| 6 | SUBSEQUENT MALIGNANT NEOPLASMS (SMN) IN CHILDHOOD CANCER PATIENTS TREATED WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) | 2013 | 1 |
| 7 | 2012 | 33 | |
| 8 | 2012 | 8 | |
| 9 | Mesenchymal stromal cells are highly effective in steroid-refractory, grade III-IV acute graft-versus-host disease in children | 2011 | 1 |
| 10 | 2009 | 95 | |
| 11 | 2009 | 16 | |
| 12 | 2007 | 22 | |
| 13 | 2002 | 15 | |
| 14 | 2002 | 55 | |
| 15 | 2002 | 14 | |
| 16 | A constitutional balanced 1;17 neuroblastoma translocation | 1997 | 1 |
| 17 | 1997 | 89 | |
| 18 | 1996 | 326 | |
| 19 | 1995 | 4 | |
| 20 | 1994 | 25 |
About Maarten Egeler
Maarten Egeler is a scholar working on Hematology, Transplantation and Oncology, having authored 29 papers that have together received 769 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (11 papers), Histiocytic Disorders and Treatments (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Renal Transplantation Outcomes and Treatments (3 papers), CAR-T cell therapy research (3 papers), Childhood Cancer Survivors' Quality of Life (3 papers), Neuroblastoma Research and Treatments (3 papers) and Transplantation: Methods and Outcomes (3 papers). The work is most often cited by research in Hematology (258 citations), Neurology (291 citations) and Transplantation (30 citations). Maarten Egeler has collaborated with scholars based in Netherlands, Canada and United States. Frequent co-authors include Huib N. Caron, Rosalyn Slater, P.A. Voûte, Jos P.M. Bökkerink, Jan de Kraker, Peter van Sluis, A. Westerveld, Rogier Versteeg, Geneviève Laureys and Ann C. Mertens. Their work appears in journals such as Bone Marrow Transplantation, Blood, Biology of Blood and Marrow Transplantation, Pediatric Blood & Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.